France’s ministry of health announced Thursday that it has approved Sativex, a cannabis-based mouth spray produced by GW pharmaceutricals. Sativex will be available in France in 2015 and will bring the nation into line with 17 other European countries, which allow marijuana to be prescribed for medical reasons.
Categories: Best of the Web, Cannabusiness, Law & Politics, Marijuana News, Medical Marijuana
Tags: Europe, france, global drug policy, GW Pharmaceuticals, sativex.
By:
Alexander Martin. Permalink: 
Shortlink: http://weedi.st/WBwGd
Tags: Europe, france, global drug policy, GW Pharmaceuticals, sativex.
By:
Alexander Martin. Permalink: Shortlink: http://weedi.st/WBwGd